225 related articles for article (PubMed ID: 34476342)
21. Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial.
Chlebowski RT; Pettinger M; Johnson KC; Wallace R; Womack C; Mossavar-Rahmani Y; Stefanick M; Wactawski-Wende J; Carbone L; Lu B; Eaton C; Walitt B; Kooperberg CL
J Acad Nutr Diet; 2013 Oct; 113(10):1302-10. PubMed ID: 23954097
[TBL] [Abstract][Full Text] [Related]
22. The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism. From the Women's Health Initiative Randomized Controlled Trial.
Blondon M; Rodabough RJ; Budrys N; Johnson KC; Berger JS; Shikany JM; Raiesdana A; Heckbert SR; Manson JE; LaCroix AZ; Siscovick D; Kestenbaum B; Smith NL; de Boer IH
Thromb Haemost; 2015 May; 113(5):999-1009. PubMed ID: 25672892
[TBL] [Abstract][Full Text] [Related]
23. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.
Robbins JA; Aragaki A; Crandall CJ; Manson JE; Carbone L; Jackson R; Lewis CE; Johnson KC; Sarto G; Stefanick ML; Wactawski-Wende J
Menopause; 2014 Feb; 21(2):116-23. PubMed ID: 23799356
[TBL] [Abstract][Full Text] [Related]
24. Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.
Tao MH; Dai Q; Chen S; Freudenheim JL; Rohan T; Wakelee H; Datta M; Wactawski-Wende J
Lung Cancer; 2017 Aug; 110():42-47. PubMed ID: 28676217
[TBL] [Abstract][Full Text] [Related]
25. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL
JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174
[TBL] [Abstract][Full Text] [Related]
26. Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast.
Luo J; Cochrane BB; Wactawski-Wende J; Hunt JR; Ockene JK; Margolis KL
Breast Cancer Res Treat; 2013 Feb; 137(3):915-25. PubMed ID: 23315265
[TBL] [Abstract][Full Text] [Related]
27. Calcium and vitamin D supplementation do not influence menopause-related symptoms: Results of the Women's Health Initiative Trial.
LeBlanc ES; Hedlin H; Qin F; Desai M; Wactawski-Wende J; Perrin N; Manson JE; Johnson KC; Masaki K; Tylavsky FA; Stefanick ML
Maturitas; 2015 Jul; 81(3):377-83. PubMed ID: 26044075
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Effect of Randomization to Calcium and Vitamin D Supplementation on Health in Older Women : Postintervention Follow-up of a Randomized Clinical Trial.
Thomson CA; Aragaki AK; Prentice RL; Stefanick ML; Manson JE; Wactawski-Wende J; Watts NB; Van Horn L; Shikany JM; Rohan TE; Lane DS; Wild RA; Robles-Morales R; Shadyab AH; Saquib N; Cauley J
Ann Intern Med; 2024 Apr; 177(4):428-438. PubMed ID: 38467003
[TBL] [Abstract][Full Text] [Related]
29. Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative.
Peila R; Lane DS; Shadyab AH; Saquib N; Strickler HD; Manson JE; Pan K; Rohan TE
Int J Cancer; 2022 Aug; 151(4):526-538. PubMed ID: 35429338
[TBL] [Abstract][Full Text] [Related]
30. Association of calcium and vitamin D supplementation with cancer incidence and cause-specific mortality in Black women: Extended follow-up of the Women's Health Initiative calcium-vitamin D trial.
Kato I; Sun J; Hastert TA; Abrams J; Larson JC; Bao W; Shadyab AH; Mouton C; Qi L; Warsinger Martin L; Manson JE
Int J Cancer; 2023 Sep; 153(5):1035-1042. PubMed ID: 36650676
[TBL] [Abstract][Full Text] [Related]
31. Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma
Arthur RS; Xue X; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1058-1066. PubMed ID: 32127398
[TBL] [Abstract][Full Text] [Related]
32. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative.
Manson JE; Allison MA; Carr JJ; Langer RD; Cochrane BB; Hendrix SL; Hsia J; Hunt JR; Lewis CE; Margolis KL; Robinson JG; Rodabough RJ; Thomas AM;
Menopause; 2010 Jul; 17(4):683-91. PubMed ID: 20551849
[TBL] [Abstract][Full Text] [Related]
33. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain.
Caan B; Neuhouser M; Aragaki A; Lewis CB; Jackson R; LeBoff MS; Margolis KL; Powell L; Uwaifo G; Whitlock E; Wylie-Rosett J; LaCroix A
Arch Intern Med; 2007 May; 167(9):893-902. PubMed ID: 17502530
[TBL] [Abstract][Full Text] [Related]
34. Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study.
Peila R; Rohan TE
Int J Cancer; 2024 Apr; 154(7):1191-1203. PubMed ID: 38013398
[TBL] [Abstract][Full Text] [Related]
35. Calcium plus vitamin D supplementation and the risk of colorectal cancer.
Wactawski-Wende J; Kotchen JM; Anderson GL; Assaf AR; Brunner RL; O'Sullivan MJ; Margolis KL; Ockene JK; Phillips L; Pottern L; Prentice RL; Robbins J; Rohan TE; Sarto GE; Sharma S; Stefanick ML; Van Horn L; Wallace RB; Whitlock E; Bassford T; Beresford SA; Black HR; Bonds DE; Brzyski RG; Caan B; Chlebowski RT; Cochrane B; Garland C; Gass M; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Jackson RD; Johnson KC; Judd H; Kooperberg CL; Kuller LH; LaCroix AZ; Lane DS; Langer RD; Lasser NL; Lewis CE; Limacher MC; Manson JE;
N Engl J Med; 2006 Feb; 354(7):684-96. PubMed ID: 16481636
[TBL] [Abstract][Full Text] [Related]
36. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.
Kabat GC; Kim MY; Woods NF; Habel LA; Messina CR; Wactawski-Wende J; Stefanick ML; Chlebowski RT; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2011 Oct; 22(10):1415-24. PubMed ID: 21750889
[TBL] [Abstract][Full Text] [Related]
37. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
39. Association of Prediagnostic Serum Levels of Vitamin D with Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cohort Study.
Peila R; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1499-1502. PubMed ID: 35437601
[TBL] [Abstract][Full Text] [Related]
40. Exemestane for breast-cancer prevention in postmenopausal women.
Goss PE; Ingle JN; Alés-Martínez JE; Cheung AM; Chlebowski RT; Wactawski-Wende J; McTiernan A; Robbins J; Johnson KC; Martin LW; Winquist E; Sarto GE; Garber JE; Fabian CJ; Pujol P; Maunsell E; Farmer P; Gelmon KA; Tu D; Richardson H;
N Engl J Med; 2011 Jun; 364(25):2381-91. PubMed ID: 21639806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
